Technology ASA (the "Company") regarding, inter alia, a share capital reduction and a private placement towards the Company's 140 largest shareholders and members of the Board of Directors and management (the "Private Placement"). Reference is furthermore made to the stock exchange announcement on 7 January 2019 regarding the general meeting`s resolution on, inter alia, the share capital decrease and the Private Placement.
The share capital changes has now been registered with the Norwegian Register of Business Enterprises. The new share capital is NOK 29,094,995 divided on 11,637,998 shares, each with a par value of NOK 2.50. The new shares will be listed and become tradable on Oslo Axess after approval and publication of a listing prospectus, which is expected to occur during February 2019.
For further information, please call Arvid Lindberg, Head of Sales & Marketing, telephone +47 98245410 or arvid@aquabiotech.no.
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on the Axess market of the Oslo Stock Exchange.